Exact Sciences completes underwritten public offering of common stock

Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has completed its previously announced underwritten public offering of its common stock at a price of $8.00 per share to the public.

Due to the exercise in full of the underwriters' over-allotment option, the company sold a total of 3,593,750 shares of common stock in the offering for aggregate gross proceeds of $28.8 million and received approximately $27.1 million of net proceeds from the offering, after deducting the underwriting discount and estimated expenses of the offering payable by the company. Robert W. Baird & Co. Incorporated acted as sole book-running manager in the offering and William Blair & Company, L.L.C. acted as co-manager for the offering.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.